Are you Dr. Drachman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000
Summary
- Dr. Jonathan Drachman, MD is an oncologist in Seattle, Washington.
Publications & Presentations
PubMed
- 31 citationsDacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cycloph...Luis Fayad, Stephen M. Ansell, Ranjana H. Advani, Bertrand Coiffier, Robert K. Stuart
Leukemia & Lymphoma. 2015-02-04 - 72 citationsA phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factorsSven de Vos, Andres Forero-Torres, Stephen M. Ansell, Brad S. Kahl, Bruce D. Cheson
Journal of Hematology & Oncology. 2014-06-12 - 25 citationsAntibody-drug conjugates: the chemistry behind empowering antibodies to fight cancerJonathan G. Drachman, Peter D. Senter
Hematology. American Society of Hematology. Education Program. 2013-12-06
Press Mentions
- StockWatch: Moderna Looks to Accelerate Cancer VaccineMarch 13th, 2023
- Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of ResearchSeptember 9th, 2021
- Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth ConferenceAugust 4th, 2021
- Join now to see all